Inhibitory mechanisms of glycoprotein fraction derived from Miscanthus sinensis for the immediate phase response of an IgE-mediated cutaneous reaction

Biological and Pharmaceutical Bulletin

Volumn 22, Issue 1, 1999, Pages 26-30

  Watanabe, Chie ^a   Satoh, Taku ^a   Tahara, Eiichi ^a   Murakami, Koji ^a   Hayashi, Kazuko ^a   Hase, Koji ^a   Andoh, Tsugunobu ^b   Kuraishi, Yasushi ^b   Kadota, Shigetoshi ^a   Nagai, Hiroichi ^c   Saiki, Ikuo ^a  

^a Dept of Cell Resources Engineering   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

^c GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

IgE mediated skin reaction; Miscanthus sinensis; Scratching; Sedation; Vascular permeability

Indexed keywords

GLYCOPROTEIN; IMMUNOGLOBULIN E;

ALLERGIC REACTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; IMMEDIATE EARLY GENE; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PROTEIN SYNTHESIS INHIBITION; PRURITUS; SCRATCHING; SEDATION; SENSITIZATION; SKIN MANIFESTATION;

EID: 0032998306     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.22.26     Document Type: Article

References (24)

1. Dolovich J., Hargreave F. E., Charlmers R., Shier J. K., Gauldie J., J. Allergy Clin. Immunol., 52, 38-46 (1973).
2. Solley G. O., Gleich G. J., Jordon R. E., Schroeter A. L., J. Clin. Invest., 58, 408-420 (1976).
3. Charlesworth E. N., J. Allergy Clin. Immunol., 94, 1240-1250 (1994).
4. Tsunematsu M., Nakai N., Inagaki N., Nagai H., J. Trad. Med., 13, 66-72 (1996).
5. Tahara E., Satoh T., Watanabe C., Nagai H., Shimada Y., Terasawa K., Saiki I., J. Trad. Med., 15, 100-108 (1998).
6. Nagai H., Sakurai T., Inagaki N., Mori H., Biol. Pharm. Bull., 18 (2), 239-245 (1995).
7. Watanabe C., Hase K., Oku T., Koizumi F., Kadota S., Nagai H., Namba T., Saiki I., Planta Med., 64, 12-17 (1998).
8. Woodward D. F., Conway J. L., Wheeler L. A., "Models in Dermatology," Vol. I, ed. by Maibach H. I., Lowe N. J., Karger, Basel, 1985. p. 187.
9. Kuraishi Y., Nagasawa T., Hayashi K., Satoh M., Eur. J. Pharmacol., 275, 229-233 (1995).
10. Puignero V., Salgado J., Qurerat J., Int. Arch. Allergy Immunol., 108, 142-147 (1995).
11. Inagaki N., Miura T., Daikoku M., Nagai H., Koda A., Pharmacology. 39 (1), 19-27 (1989).
12. Wang J. P., Raung S. L., Chang L. C., Kuo S. C., Eur. J. Pharmacol., 272 (1), 87-95 (1995).
13. Nicholson A. N., Lancet, 2, 211-212 (1983).
14. Nicholson A. N., Stone B. M., Eur. J. Clin Pharmacol., 30, 27-32 (1986).
15. Bonham C. A., Thomson A. W., Clin. Exp. Immunol., 102, 1-5 (1995).
16. Benyon R. C., Clin. Exp. Allergy, 19 (4), 375-387 (1989).
17. Armstrong D., Dry R. M. L., Keele C., Markham J. W., J. Physiol., 120, 326-351 (1953).
18. Fjellner B., Hagermark O., Acta Derm.-Venereol. (Stockh), 59, 502-512 (1979).
19. Wahlgren C. F., Ekblom A., Acta Derm.-Venereol. (Stockh), 71, 205-208 (1991).
20. Winter J. C., Pharmacol. Biochem. Behavior, 22 (1), 15-17 (1985).
21. Hey J. A., Del Prado M., Cuss F. M., Egan R. W., Sherwood J., Lin C. C., Kreutner W., Clin. Exp. Allergy, 25 (10), 974-984 (1995).
22. Behrendt H., Ring J., Clin. Exp. Allergy, 20 Suppl. 4, 25-30 (1990).
23. Berth-Jones J., Graham-Brown B. J., Br. J. Dermatol., 121, 635-637 (1989).
24. Krause L., Shuster S., Br. Med. J., 287, 1199-1200 (1983).